Primary Job Title Independent Director Primary Organization EyeTechCare
Location Rhone-Alpes, France, Europe Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
Investor Type Investor Stage
LinkedIn View on LinkedIn
Bernard Chauvin, a renowned authority in the field of ophthalmology, sits on the company's Board of Directors.
March 12, 2013 – EyeTechCare SA, has secured a third round of funding amounting to EUR 10 million. Bernard Chauvin, a private investor, has taken an equity stake in the company alongside two of the existing investors which also
contributed to this round of funding: the capital investment company Omnes Capital (formerly Crédit Agricole Private Equity) and the Lyon-based insurer SHAM.
Bernard Chauvin is a physician specializing in ophthalmology. He headed the Laboratoires Chauvin for 27 years (until its acquisition by Bausch & Lomb), prior to joining Neurotech, a French biotechnology company where he served as Chief Executive Officer until 2004. Since then, he has taken an active role as a director in the development of a number of pharmaceutical and biotechnology companies.
